Biblio
Journal Article
Usart M, Stetka J, Paz DLuque, Hansen N, Kimmerlin Q, Fonseca TAlmeida, Lock M, Kubovcakova L, Karjalainen R, Hao-Shen H, et al. Loss of Dnmt3a increased self-renewal and resistance to pegIFNα in JAK2-V617F-positive myeloproliferative neoplasms. Blood. 2024.
Rai S, Zhang Y, Grockowiak E, Kimmerlin Q, Hansen N, Stoll CB, Usart M, Paz DLuque, Hao-Shen H, Zhu Y, et al. IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells. Blood Adv. 2024.
Usart M, Hansen N, Stetka J, Fonseca TAlmeida, Guy A, Kimmerlin Q, Rai S, Hao-Shen H, Roux J, Dirnhofer S, et al. The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN. Blood Adv. 2024.